Taysha Gene Therapies, Inc. TSHA Market capitalization

Market capitalization at other companies

Ionis PharmaceuticalsIONS

$13.1B+108%

BiogenBIIB

$31.9B+72.4%

Acadia PharmaceuticalsACAD

$4.33B+15.5%

Ultragenyx PharmaceuticalRARE

$3.29B-6.4%

uniQureQURE

$3.17B+307%

Design Therapeutics, Inc.DSGN

$656.19M+199%

FAQ

What is Taysha Gene Therapies, Inc.'s market capitalization?

Taysha Gene Therapies, Inc. (TSHA) reported market capitalization of $1.28B in Q1 2026.

How has Taysha Gene Therapies, Inc.'s market capitalization changed year-over-year?

Taysha Gene Therapies, Inc.'s market capitalization increased by 350.6% year-over-year, from $284.95M to $1.28B.

What is the long-term trend for Taysha Gene Therapies, Inc.'s market capitalization?

Over 5 years (2020 to 2025), Taysha Gene Therapies, Inc.'s market capitalization has grown at a 12.0% compound annual growth rate (CAGR), from $854.96M to $1.51B.

What does market capitalization mean?

The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.